CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade

(2019) Weiwei Zhao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The molecular markers of cancer stem cells in head and neck tumors

(2019) Si Si Yu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The changing therapeutic landscape of head and neck cancer

(2019) John D. Cramer et al.   Nature Reviews Clinical Oncology

CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer

(2019) Y. Xiao et al.   JOURNAL OF DENTAL RESEARCH

Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma

(2019) Xi Chen et al.   Molecular Oncology

Targeting CMTM6 suppresses stem cell-like properties and enhances antitumor immunity in head and neck squamous cell carcinoma

(2019) Lei Chen et al.   Cancer Immunology Research

Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma

(2018) Hao Li et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Regulation and Function of the PD-L1 Checkpoint

(2018) Chong Sun et al.   IMMUNITY

Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma

(2018) J.M. Moskovitz et al.   JOURNAL OF DENTAL RESEARCH

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

(2018) Ezra E W Cohen et al.   LANCET

TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma

(2017) Lei Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

(2017) Riccardo Mezzadra et al.   NATURE

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

(2017) Marian L. Burr et al.   NATURE

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

(2017) Tsukasa Shibue et al.   Nature Reviews Clinical Oncology

Genetic etiology of oral cancer

(2017) Johar Ali et al.   ORAL ONCOLOGY

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma

(2016) Chan-Young Ock et al.   Oncotarget

Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway

(2016) Wanqiong Yuan et al.   Oncotarget

Immunology and Immunotherapy of Head and Neck Cancer

(2015) Robert L. Ferris   JOURNAL OF CLINICAL ONCOLOGY

Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma

(2015) Patcharee Ritprajak et al.   ORAL ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma

(2012) Chao Chen et al.   CANCER LETTERS

Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor

(2012) Atsuko Miyazaki et al.   PLoS One

B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin

(2010) Yujia Cao et al.   CANCER RESEARCH

Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation

(2010) Markus Plate et al.   MOLECULES AND CELLS